Literature DB >> 74499

Pool-priming: A means of generating T lymphocytes cytotoxin to tumour or virus-infected cells.

M L Bach, F H Bach, J M Zarling.   

Abstract

It is proposed that cells cytotoxic for autologous or syngeneic tumour cells can be produced in vitro by sensitisation of lymphocytes to a pool of normal cells from 20 unrelated individuals. Restriction on molecules that can serve as cytotoxic determinants (C.D.), may explain why a random pool of cells from 20 people could present essentially all of the determinants (C.D.) may explain why a random pool of occur because of extensive cross-reactivity of antigens on tumour cells with normal alloantigens present in the stimulating pool.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 74499     DOI: 10.1016/s0140-6736(78)90364-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  5 in total

1.  Killer cells induced by stimulation with allogeneic tumor cells and subsequent culture with recombinant interleukin-2.

Authors:  T Fukiage; H Murakami; M Eura; T Ikawa; T Ishikawa
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

2.  Sensitization of lymphocytes against pooled allogeneic cells. I. Generation of cytotoxicity against autologous human lymphoblastoid cell lines.

Authors:  J M Zarling; F H Bach
Journal:  J Exp Med       Date:  1978-05-01       Impact factor: 14.307

3.  In vitro elicitation of cytotoxic response against a nonimmunogenic murine tumor by allosensitization.

Authors:  B Leshem; B Gotsman; E Kedar
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

4.  Human anti-lymphoma responses generated in vitro and in vivo following sensitization with allogeneic leukocytes.

Authors:  J M Zarling; N E Kay; B Grant; M Yasukawa; F H Bach
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

5.  Tumour-reactive lymphocytes stimulated in mixed lymphocyte and tumour culture. Clonal analysis of effector cells in cytotoxic and proliferative assays.

Authors:  B M Vose; W White
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.